A human brain showing frontotemporal lobar degeneration causing frontotemporal dementia.
Find information on thousands of medical conditions and prescription drugs.

Frontotemporal dementia

Frontotemporal dementia (FTD) is one of three clinical syndromes associated with frontotemporal lobar degeneration. FTD selectively affects the frontal lobe of the brain and may extend backward to the temporal lobe. There are two main types: Pick's disease, which has been recognised for many years, and Dementia of the Frontal Lobe Type (DFLT), more recently described. The pathology of these two conditions is different although the clinical manifestations are similar. more...

Home
Diseases
A
B
C
D
E
F
Fabry's disease
Facioscapulohumeral...
Factor V Leiden mutation
Factor VIII deficiency
Fallot tetralogy
Familial adenomatous...
Familial Mediterranean fever
Familial periodic paralysis
Familial polyposis
Fanconi syndrome
Fanconi's anemia
Farber's disease
Fascioliasis
Fatal familial insomnia
Fatty liver
Febrile seizure
Fibrodysplasia ossificans...
Fibromatosis
Fibrosarcoma
Fibrosis
Fibrous dysplasia
Filariasis
Fissured tongue
Fitz-Hugh-Curtis syndrome
Flesh eating bacteria
Fluorosis
Focal dystonia
Foix-Alajouanine syndrome
Follicular lymphoma
Fountain syndrome
Fragile X syndrome
Fraser syndrome
FRAXA syndrome
Friedreich's ataxia
Frontotemporal dementia
Fructose intolerance
Fructose-1,6-bisphosphatase...
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Medicines

The frontal lobe is involved in many aspects of mental function. These include motivation and drive, classifying and categorizing, emotion and personality. Social behaviour is also influenced as is appetite.

Frontal dysfunction may therefore lead to apathy or conversely disinhibition, disordered high level thinking- perseveration, and personality change. The manifestation will depend on which part of the lobe is more affected — dorsolateral or orbitomedial. Many routine dementia assessments do not test the frontal lobe.

Frontotemporal dementia sometimes occurs with Motor neurone disease.

Further reading

  • A collection of articles about Frontotemporal dementia in the journal Neurology
  • Radin, Lisa. "What If It's Not Alzheimer's: A Caregiver's Guide to Dementia." Prometheus Books. 2003.

Read more at Wikipedia.org


[List your site here Free!]


Diagnosis and treatment of early Alzheimer's disease - Tips from Other Journals
From American Family Physician, 3/15/04 by Bill Zepf

Alzheimer's disease accounts for the majority of dementia cases, but a substantial number of persons may be affected by other dementias, including vascular dementia (10 to 20 percent of cases), dementia with Lewy bodies (10 to 15 percent), and frontotemporal dementia (5 to 15 percent). Kawas presents a clinical review of the early diagnosis and treatment of dementia.

The diagnostic criteria for dementia require the patient to have cognitive impairment severe enough to cause social or occupational disability in at least two domains, including memory, language, calculations, orientation, and judgment. The author recommends using a formal testing instrument, such as the Mini-Mental State Examination (MMSE), for detection and follow-up of cognitive decline. Patients with disabling cognitive impairment in at least two domains generally score less than 24 on the MMSE. Patients with only mild cognitive impairment usually score 24 or higher but typically do poorly on the memory component of the examination, which tests for recall of three named objects. The MMSE score should be adjusted for age and education level. A table of cutoff values for normal scores is available at http://www.nemc.org/ psych/mmse.asp.

In addition to the MMSE, the recommended work-up for a patient reporting early signs of cognitive decline includes a thorough history and physical examination. Special attention should be given to screening for medications that may be impairing cognition, such as prescription and over-the-counter sleeping pills, antianxiety medications, and cold and allergy preparations. Non-contrast-enhanced computed tomography or magnetic resonance imaging of the brain is recommended, as is a limited battery of laboratory tests (i.e., electrolyte levels; renal, hepatic, and thyroid function tests; vitamin B12 level). The author notes that B12 deficiency or thyroid dysfunction is rarely the sole cause of dementia but commonly coexist and warrant treatment to improve function. All patients with cognitive decline should be asked about possible depression, which can mimic dementia and be a coexistent complication.

An insidious onset of cognitive problems and steady progression of impairment suggests Alzheimer's disease. However, there is no laboratory or neuropsychiatric test that can definitively diagnose the disease. The presence of certain atypical features (see the accompanying table) suggests the possibility of an alternative diagnosis for the cognitive impairment.

The author concludes with a summary of the limited pharmacotherapeutic options available for the treatment of Alzheimer's disease and the psychosocial support measures that should be explored with the patient and caregivers.

Kawas CH. Early Alzheimer's disease. N Engl J Med September 11, 2003;349:1056-63.

COPYRIGHT 2004 American Academy of Family Physicians
COPYRIGHT 2004 Gale Group

Return to Frontotemporal dementia
Home Contact Resources Exchange Links ebay